Swiftmerge Acquisition Operating Margin 1970-1969 | ANNA

Current and historical operating margin for Swiftmerge Acquisition (ANNA) over the last 10 years. The current operating profit margin for Swiftmerge Acquisition as of December 31, 1969 is 0.00%.
Swiftmerge Acquisition Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
Sector Industry Market Cap Revenue
Medical MED-DRUGS $0.042B $0.000B
Swiftmerge Acquisition Corp. entered into definitive merger agreement with HDL Therapeutics Inc.
Stock Name Country Market Cap PE Ratio
NPK (NPKI) United States $0.626B 27.85
Performant Healthcare (PHLT) United States $0.245B 0.00
FTAC Emerald Acquisition (FLDD) United States $0.158B 0.00
Insight Acquisition (AMOD) United States $0.023B 0.00
Hanryu Holdings (GITS) South Korea $0.017B 0.00
Pieris Pharmaceuticals (PVLA) United States $0.016B 0.00
LQR House (YHC) United States $0.011B 0.00
ATIF Holdings (ZBAI) China $0.009B 0.00
Lion Electric (LEVGQ) Canada $0.000B 0.00